doi.org/10.1038/s41523-022-00467-1

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

,

Sara M. Tolaney

,

..., Lisa A. Carey

npj Breast Cancer

Volume: 8, Issue: 1

Published: Aug 29, 2022

Paper Fields

Paper Details

Title

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

DOI

doi.org/10.1038/s41523-022-00467-1

Published Date

Aug 29, 2022

Journal

npj Breast Cancer

Volume

8

Issue

1

Notes

History